Global R&D Pipeline
My Favorite
Hot Targets:
VEGF-A
Back
Total number of drugs
257
Phase II and later clinical stages
34.2%
Involving companies
372
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
| Drug | Drug Name En | Drug Type | Treatment Field | Mechanism of Action | Originator | Developer | Indication | Highest Development Stage | Highest Development Stage (China) | Approved Countries/Regions | Approved Time | Approved Time (China) | Special Review | ADC Type | ADC Linker | ADC Payload | ADC DAR | Drug Name | Antibody Type | ADC Linking Site | Operation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bevacizumab biosimilar(MiGenTra) | Bevacizumab biosimilar(MiGenTra) | Biosimilar Monoclonal antibody | Neoplasms | VEGF-A inhibitors Angiogenesis inhibitors | Migentra GmbH | Migentra GmbH | Preclinical | - | - | - | - | - | - | - | - | - | Bevacizumab biosimilar(MiGenTra) | - | - | detail > | |
| Aflibercept Biosimilar (Wincal Biopharm) | Aflibercept Biosimilar (Wincal Biopharm) | Fc fusion protein Biosimilar | Cardiovascular Diseases Congenital Disorders Endocrinology and Metabolic Disease Eye Diseases | PGF inhibitors VEGF-A inhibitors | Wincal Biopharm Inc. | Wincal Biopharm Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Aflibercept Biosimilar (Wincal Biopharm) | - | - | detail > | |
| Bevacizumab(Vesselon) | Bevacizumab(Vesselon) | Biosimilar Monoclonal antibody | Neoplasms Other Diseases | VEGF-A inhibitors Angiogenesis inhibitors | Vesselon, Inc. | Vesselon, Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Bevacizumab(Vesselon) | - | - | detail > | |
| Aflibercept Biosimilar (PanGen Biotech) | Aflibercept Biosimilar (PanGen Biotech) | Fc fusion protein Biosimilar | Congenital Disorders Eye Diseases | PGF inhibitors VEGF-A inhibitors | PanGen Biotech, Inc. | PanGen Biotech, Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Aflibercept Biosimilar (PanGen Biotech) | - | - | detail > | |
| Bevacizumab Biosimilar(Wincal Biopharm) | Bevacizumab Biosimilar(Wincal Biopharm) | Biosimilar Monoclonal antibody | Congenital Disorders Eye Diseases | VEGF-A inhibitors Angiogenesis inhibitors | Wincal Biopharm Inc. | Wincal Biopharm Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Bevacizumab Biosimilar(Wincal Biopharm) | - | - | detail > | |
| Brolucizumab Biosimilar(Wincal Biopharm) | Brolucizumab Biosimilar(Wincal Biopharm) | Single-chain FV antibody fragment Biosimilar | Congenital Disorders Eye Diseases | VEGF-A inhibitors | Wincal Biopharm Inc. | Wincal Biopharm Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Brolucizumab Biosimilar(Wincal Biopharm) | - | - | detail > | |
| Ranibizumab biosimilar(Spinnaker Biosciences) | Ranibizumab biosimilar(Spinnaker Biosciences) | Biosimilar Monoclonal antibody | Congenital Disorders Eye Diseases | VEGF-A inhibitors | Spinnaker Biosciences, Inc. | Spinnaker Biosciences, Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Ranibizumab biosimilar(Spinnaker Biosciences) | - | - | detail > | |
| Bevacizumab Biosimilar (BioIntegrator) | Bevacizumab Biosimilar (BioIntegrator) | Biosimilar Monoclonal antibody | Neoplasms | VEGF-A inhibitors Angiogenesis inhibitors | BioIntegrator LLC | BioIntegrator LLC | Preclinical | - | - | - | - | - | - | - | - | - | Bevacizumab Biosimilar (BioIntegrator) | - | - | detail > | |
| Bevacizumab Biosimilar (HEC) | Bevacizumab Biosimilar (HEC) | Biosimilar Monoclonal antibody | Neoplasms | VEGF-A inhibitors Angiogenesis inhibitors | Sunshine Lake Pharma Co., Ltd. | Sunshine Lake Pharma Co., Ltd. | Preclinical | Preclinical | - | - | - | - | - | - | - | - | Bevacizumab Biosimilar (HEC) | - | - | detail > | |
| Aflibercept biosimilar (IVY Pharma) | Aflibercept biosimilar (IVY Pharma) | Fc fusion protein Biosimilar | Cardiovascular Diseases Congenital Disorders Endocrinology and Metabolic Disease Eye Diseases Other Diseases | PGF inhibitors VEGF-A inhibitors | Ivy Pharma, Inc. | Ivy Pharma, Inc. | Preclinical | - | - | - | - | - | - | - | - | - | Aflibercept biosimilar (IVY Pharma) | - | - | detail > |
Total 257 data
1
2
3
4
5
6
...
25
26
